{"id":75131,"date":"2024-06-05T13:25:02","date_gmt":"2024-06-05T13:25:02","guid":{"rendered":"https:\/\/www.africa-press.net\/rwanda\/all-news\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding"},"modified":"2024-06-05T14:25:44","modified_gmt":"2024-06-05T14:25:44","slug":"biontech-names-three-priority-areas-after-securing-rwf180bn-funding","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding","title":{"rendered":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding"},"content":{"rendered":"

Africa-Press – Rwanda. <\/strong><\/span>Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (approximately Rwf188 billion) from the Coalition for Epidemic Preparedness Innovations (CEPI), in a bid to strengthen Africa\u2019s mRNA vaccine ecosystem.<\/p>\n

The Germany-based vaccine manufacturer said it would use the funds to set up mRNA vaccine research and development (R&D), and clinical and commercial-scale manufacturing capabilities at its existing facility in Kigali, Rwanda.<\/p>\n

These capacities are, among others, expected to be critical in enhancing readiness for potential future epidemic and pandemic challenges on the continent by building a sustainable and resilient end-to-end ecosystem.<\/p>\n

The latest funding follows that of up to $90m that the coalition (CEPI) granted BioNTech in September last year to develop mpox vaccine candidates.<\/p>\n

According to BioNTech, the partnership aims to back the company\u2019s existing efforts in three key areas for Africa\u2019s pandemic preparedness and vaccine ecosystem;<\/p>\n

Commercial-scale manufacturing<\/b><\/p>\n

Information obtained from BioNTech indicates that CEPI\u2019s funding will support measures required for the regulatory authorisation of its facility in Rwanda, starting in 2025.<\/p>\n

Inaugurated in December 2023, the 300,000 square meters facility is based on the company\u2019s digitally enabled modular manufacturing units called BioNTainers, designed to manufacture a range of mRNA-based vaccines.<\/p>\n

President Kagame and other dignitaries officially inaugurate BioNTech\u2019s vaccine manufacturing plant in Kigali on December 18, 2023. Information obtained from BioNTech indicates that CEPI\u2019s funding will support measures required for the regulatory authorisation of its facility in Rwanda, starting in 2025.<\/p>\n

Under the terms of the agreement, in the event of a disease outbreak or a potential disease outbreak, BioNTech would dedicate up to half of the facility\u2019s manufacturing capacity to produce emergency response mRNA vaccines, subject to regulatory authorisation.<\/p>\n

This effort aims to, among others, contribute to the 100 Days Mission, a global initiative to accelerate the development of safe and effective vaccines in response to an outbreak of a novel Disease (X) in as little as 100 days.<\/p>\n

The 100 Days Mission is spearheaded by CEPI and embraced by the G7, and G20, among other industry leaders.<\/p>\n

End-to-end clinical-scale manufacturing of novel vaccine candidates<\/b><\/p>\n

Most of the CEPI funding will be allocated to set up clinical-scale manufacturing capabilities for mRNA-based vaccine candidates at the Kigali facility. Details on what percentage of the total funding would be allocated were not available by press time.<\/p>\n

This would allow the BioNTech facility to manufacture on both a clinical and commercial scale, thus broadening the manufacturing scope, and supporting a sustainable use for the facility while strengthening the wider African vaccine development ecosystem.<\/p>\n

BioNTech says it is also separately proceeding with the development of prophylactic mRNA vaccines targeting infectious diseases such as tuberculosis, malaria, and HIV, and is also focusing on diseases with epidemic and pandemic potential, including mpox.<\/p>\n

Clinical trials for tuberculosis, malaria, and mpox vaccine programs are underway in Europe, the United States, and South Africa.<\/p>\n

BioNTech also aims to conduct clinical trials in Africa for vaccine candidates against malaria, HIV, and mpox.<\/p>\n

Strengthening the African R&D ecosystem<\/b><\/p>\n

The funding, BioNTech said, would enable the company to dedicate manufacturing capacities to third-party projects to support pre-clinical and clinical activities, including those by African-based researchers, academic groups, local businesses, public-private partnerships, and non-profit organisations.<\/p>\n

Reacting to the eligibility criteria, BioNTech said the projects would be selected in partnership with global, regional, and national healthcare organisations.<\/p>\n

\u201cThis effort by BioNTech and CEPI has the potential to enable R&D activities for novel mRNA-based vaccine candidates against pathogens with epidemic or pandemic potential,\u201d a statement reads in part.<\/p>\n

For More News And Analysis About Rwanda<\/a> Follow Africa-Press<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Africa-Press – Rwanda. Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (approximately Rwf188 billion) from the Coalition for Epidemic Preparedness Innovations (CEPI), in a bid to strengthen Africa\u2019s mRNA vaccine ecosystem. The Germany-based vaccine manufacturer said it would use the funds to set up mRNA […]<\/p>\n","protected":false},"author":84,"featured_media":75130,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24,15],"tags":[760,763,963,4583,758],"class_list":["post-75131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-news","category-economy","tag-africa-press","tag-africa-press-rwanda","tag-biontech","tag-cepi","tag-rwanda"],"yoast_head":"\nBioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding - Rwanda<\/title>\n<meta name=\"description\" content=\"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding\" \/>\n<meta property=\"og:description\" content=\"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\" \/>\n<meta property=\"og:site_name\" content=\"Rwanda\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-05T13:25:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-05T14:25:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"562\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditoren\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditoren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\"},\"author\":{\"name\":\"cfeditoren\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"headline\":\"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding\",\"datePublished\":\"2024-06-05T13:25:02+00:00\",\"dateModified\":\"2024-06-05T14:25:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\"},\"wordCount\":613,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg\",\"keywords\":[\"Africa Press\",\"Africa Press-Rwanda\",\"BioNTech\",\"CEPI\",\"Rwanda\"],\"articleSection\":[\"all news\",\"Economy\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\",\"url\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\",\"name\":\"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding - Rwanda\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg\",\"datePublished\":\"2024-06-05T13:25:02+00:00\",\"dateModified\":\"2024-06-05T14:25:44+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\"},\"description\":\"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg\",\"width\":1000,\"height\":562,\"caption\":\"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.africa-press.net\/rwanda\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#website\",\"url\":\"https:\/\/www.africa-press.net\/rwanda\/\",\"name\":\"Rwanda\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/rwanda\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb\",\"name\":\"cfeditoren\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding - Rwanda","description":"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding","og_locale":"en_US","og_type":"article","og_title":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding","og_description":"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...","og_url":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding","og_site_name":"Rwanda","article_published_time":"2024-06-05T13:25:02+00:00","article_modified_time":"2024-06-05T14:25:44+00:00","og_image":[{"width":1000,"height":562,"url":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg","type":"image\/jpeg"}],"author":"cfeditoren","twitter_card":"summary_large_image","twitter_misc":{"Written by":"cfeditoren","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding"},"author":{"name":"cfeditoren","@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"headline":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding","datePublished":"2024-06-05T13:25:02+00:00","dateModified":"2024-06-05T14:25:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding"},"wordCount":613,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg","keywords":["Africa Press","Africa Press-Rwanda","BioNTech","CEPI","Rwanda"],"articleSection":["all news","Economy"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding","url":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding","name":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding - Rwanda","isPartOf":{"@id":"https:\/\/www.africa-press.net\/rwanda\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg","datePublished":"2024-06-05T13:25:02+00:00","dateModified":"2024-06-05T14:25:44+00:00","author":{"@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb"},"description":"Covid-19 vaccine manufacturer BioNTech last week announced that it had secured a funding commitment of up to $145m (appr ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#primaryimage","url":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg","contentUrl":"https:\/\/static.africa-press.net\/rwanda\/sites\/23\/2024\/06\/sm_1717584743.236238.jpg","width":1000,"height":562,"caption":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/rwanda\/economy\/biontech-names-three-priority-areas-after-securing-rwf180bn-funding#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.africa-press.net\/rwanda\/"},{"@type":"ListItem","position":2,"name":"BioNTech names three \u201cpriority\u201d areas after securing Rwf180bn funding"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/rwanda\/#website","url":"https:\/\/www.africa-press.net\/rwanda\/","name":"Rwanda","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/rwanda\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/rwanda\/#\/schema\/person\/068c7ab4e9634ae78ec5d54ec46598bb","name":"cfeditoren"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts\/75131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/users\/84"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/comments?post=75131"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/posts\/75131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/media\/75130"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/media?parent=75131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/categories?post=75131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/rwanda\/wp-json\/wp\/v2\/tags?post=75131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}